All Categories
ERLONAT 100

ERLONAT 100

ERLOTINIB TABLET 100MG is a referred to as an epidermal growth factor receptor (EGFR) inhibitor. This oral medicine is prescribed to patients with non-small cell lung cancer (NSCLC) & metastatic pancreatic cancer. This medicine must be consumed on an empty stomach or 1 hour before eating. It is highly effective for cancer treatment.

Manufacture : NATCO PHARMA LTD

Active Ingredient: ERLOTINIB TABLET 100MG

Packing : 30 TABLETS

Related Products

XBIRA 250MG

XBIRA 250MG

Manufacture : Cipla Pharmaceuticals

Abiraterone 250mg is a formulation of Zytiga & prednisone that is identified as

VIVITRA 440

VIVITRA 440

Manufacture : Zydus Cadila

Transtuzumab antibodies are a relatively new type of cancer therapy.

Erlocip 150

Erlocip 150

Manufacture : Cipla Pharmaceuticals

The Erlocip 150 tablets are used for the individuals who suffer from consistent

Most Viewed

Blog

Blog2

Blog2

  • 08 Oct, 2018
  • Posted by
  • Admin

Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et

Blog1

Blog1

  • 26 Oct, 2018
  • Posted by
  • Admin

Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et

Blog

Blog

  • 09 Oct, 2018
  • Posted by
  • Admin

Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et

FOLLOW US ON
© 2020 Universal Health Care and Suppliers. All Rights Reserved.